nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—hypertension—metabolic syndrome X	0.911	1	CtDrD
Candesartan—AGTR1—artery—metabolic syndrome X	0.00365	0.143	CbGeAlD
Candesartan—AGTR1—endothelium—metabolic syndrome X	0.00308	0.12	CbGeAlD
Candesartan—AGTR1—blood vessel—metabolic syndrome X	0.00284	0.111	CbGeAlD
Candesartan—UGT1A3—liver—metabolic syndrome X	0.00184	0.0719	CbGeAlD
Candesartan—PTGS1—artery—metabolic syndrome X	0.00161	0.0627	CbGeAlD
Candesartan—PTGS1—endothelium—metabolic syndrome X	0.00136	0.0529	CbGeAlD
Candesartan—AGTR1—cardiovascular system—metabolic syndrome X	0.00127	0.0495	CbGeAlD
Candesartan—PTGS1—blood vessel—metabolic syndrome X	0.00125	0.0488	CbGeAlD
Candesartan—AGTR1—kidney—metabolic syndrome X	0.00124	0.0485	CbGeAlD
Candesartan—Pranlukast—TNF—metabolic syndrome X	0.00121	0.359	CrCbGaD
Candesartan—AGTR1—adipose tissue—metabolic syndrome X	0.00112	0.0437	CbGeAlD
Candesartan—Telmisartan—PPARG—metabolic syndrome X	0.00105	0.309	CrCbGaD
Candesartan—AGTR1—liver—metabolic syndrome X	0.000785	0.0306	CbGeAlD
Candesartan—ABCB1—blood vessel—metabolic syndrome X	0.000739	0.0289	CbGeAlD
Candesartan—CYP2C8—kidney—metabolic syndrome X	0.000673	0.0263	CbGeAlD
Candesartan—CYP2C9—cardiovascular system—metabolic syndrome X	0.000611	0.0239	CbGeAlD
Candesartan—PTGS1—cardiovascular system—metabolic syndrome X	0.000558	0.0218	CbGeAlD
Candesartan—PTGS1—kidney—metabolic syndrome X	0.000546	0.0213	CbGeAlD
Candesartan—Losartan—ACE—metabolic syndrome X	0.000499	0.148	CrCbGaD
Candesartan—PTGS1—adipose tissue—metabolic syndrome X	0.000492	0.0192	CbGeAlD
Candesartan—CYP2C8—liver—metabolic syndrome X	0.000425	0.0166	CbGeAlD
Candesartan—Valsartan—ALB—metabolic syndrome X	0.000419	0.124	CrCbGaD
Candesartan—CYP2C9—liver—metabolic syndrome X	0.000378	0.0148	CbGeAlD
Candesartan—ABCB1—cardiovascular system—metabolic syndrome X	0.00033	0.0129	CbGeAlD
Candesartan—ABCB1—kidney—metabolic syndrome X	0.000323	0.0126	CbGeAlD
Candesartan—ABCB1—adipose tissue—metabolic syndrome X	0.000291	0.0114	CbGeAlD
Candesartan—Renal impairment—Metformin—metabolic syndrome X	0.000278	0.0596	CcSEcCtD
Candesartan—Angina pectoris—Metformin—metabolic syndrome X	0.000223	0.0478	CcSEcCtD
Candesartan—Sweating increased—Metformin—metabolic syndrome X	0.000223	0.0478	CcSEcCtD
Candesartan—Neutropenia—Metformin—metabolic syndrome X	0.000214	0.0458	CcSEcCtD
Candesartan—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.000213	0.0456	CcSEcCtD
Candesartan—Losartan—ALB—metabolic syndrome X	0.000205	0.0605	CrCbGaD
Candesartan—ABCB1—liver—metabolic syndrome X	0.000204	0.00796	CbGeAlD
Candesartan—Rhinitis—Metformin—metabolic syndrome X	0.000184	0.0393	CcSEcCtD
Candesartan—Hepatitis—Metformin—metabolic syndrome X	0.000183	0.0392	CcSEcCtD
Candesartan—Oedema peripheral—Metformin—metabolic syndrome X	0.00018	0.0387	CcSEcCtD
Candesartan—Malnutrition—Metformin—metabolic syndrome X	0.000159	0.0342	CcSEcCtD
Candesartan—Palpitations—Metformin—metabolic syndrome X	0.000141	0.0302	CcSEcCtD
Candesartan—Hypertension—Metformin—metabolic syndrome X	0.000138	0.0295	CcSEcCtD
Candesartan—Chest pain—Metformin—metabolic syndrome X	0.000136	0.0291	CcSEcCtD
Candesartan—Myalgia—Metformin—metabolic syndrome X	0.000136	0.0291	CcSEcCtD
Candesartan—Thrombocytopenia—Metformin—metabolic syndrome X	0.000127	0.0273	CcSEcCtD
Candesartan—Hyperhidrosis—Metformin—metabolic syndrome X	0.000126	0.027	CcSEcCtD
Candesartan—Hypotension—Metformin—metabolic syndrome X	0.000122	0.0261	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000118	0.0254	CcSEcCtD
Candesartan—Paraesthesia—Metformin—metabolic syndrome X	0.000117	0.025	CcSEcCtD
Candesartan—Dyspnoea—Metformin—metabolic syndrome X	0.000116	0.0249	CcSEcCtD
Candesartan—Somnolence—Metformin—metabolic syndrome X	0.000116	0.0248	CcSEcCtD
Candesartan—Dyspepsia—Metformin—metabolic syndrome X	0.000114	0.0245	CcSEcCtD
Candesartan—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000112	0.0241	CcSEcCtD
Candesartan—Fatigue—Metformin—metabolic syndrome X	0.000112	0.024	CcSEcCtD
Candesartan—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000106	0.0228	CcSEcCtD
Candesartan—Urticaria—Metformin—metabolic syndrome X	0.000103	0.0221	CcSEcCtD
Candesartan—Abdominal pain—Metformin—metabolic syndrome X	0.000103	0.022	CcSEcCtD
Candesartan—Asthenia—Metformin—metabolic syndrome X	9.33e-05	0.02	CcSEcCtD
Candesartan—Pruritus—Metformin—metabolic syndrome X	9.2e-05	0.0197	CcSEcCtD
Candesartan—Diarrhoea—Metformin—metabolic syndrome X	8.9e-05	0.0191	CcSEcCtD
Candesartan—Dizziness—Metformin—metabolic syndrome X	8.6e-05	0.0184	CcSEcCtD
Candesartan—Vomiting—Metformin—metabolic syndrome X	8.27e-05	0.0177	CcSEcCtD
Candesartan—Rash—Metformin—metabolic syndrome X	8.2e-05	0.0176	CcSEcCtD
Candesartan—Dermatitis—Metformin—metabolic syndrome X	8.19e-05	0.0176	CcSEcCtD
Candesartan—Headache—Metformin—metabolic syndrome X	8.15e-05	0.0175	CcSEcCtD
Candesartan—Nausea—Metformin—metabolic syndrome X	7.72e-05	0.0166	CcSEcCtD
Candesartan—AGTR1—Signaling Pathways—GHRL—metabolic syndrome X	3.54e-05	0.000645	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	3.48e-05	0.000634	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GOT1—metabolic syndrome X	3.48e-05	0.000633	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GGT1—metabolic syndrome X	3.48e-05	0.000633	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	3.44e-05	0.000627	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—G6PD—metabolic syndrome X	3.43e-05	0.000625	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	3.39e-05	0.000616	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	3.38e-05	0.000616	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CNR1—metabolic syndrome X	3.36e-05	0.000611	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HDAC3—metabolic syndrome X	3.35e-05	0.00061	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	3.33e-05	0.000606	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	3.29e-05	0.000599	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—EPHX2—metabolic syndrome X	3.28e-05	0.000597	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—MLXIPL—metabolic syndrome X	3.28e-05	0.000597	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPA—metabolic syndrome X	3.27e-05	0.000596	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GCKR—metabolic syndrome X	3.27e-05	0.000596	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	3.24e-05	0.000591	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FMO3—metabolic syndrome X	3.21e-05	0.000584	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PLA2G6—metabolic syndrome X	3.17e-05	0.000577	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	3.15e-05	0.000573	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA5—metabolic syndrome X	3.14e-05	0.000571	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	3.12e-05	0.000569	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—G6PC2—metabolic syndrome X	3.08e-05	0.000562	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	3.07e-05	0.000559	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	3.05e-05	0.000555	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	3.05e-05	0.000555	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CCL2—metabolic syndrome X	3.03e-05	0.000552	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	3.01e-05	0.000549	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FMO3—metabolic syndrome X	3e-05	0.000546	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.99e-05	0.000544	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	2.96e-05	0.000539	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.95e-05	0.000538	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOB—metabolic syndrome X	2.95e-05	0.000537	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.93e-05	0.000534	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—TRIB3—metabolic syndrome X	2.92e-05	0.000531	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PLA2G4A—metabolic syndrome X	2.87e-05	0.000523	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	2.86e-05	0.00052	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—EPHX2—metabolic syndrome X	2.86e-05	0.00052	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.84e-05	0.000517	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	2.84e-05	0.000516	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—LPL—metabolic syndrome X	2.82e-05	0.000513	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	2.76e-05	0.000502	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	2.75e-05	0.000501	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF2—metabolic syndrome X	2.74e-05	0.0005	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—G6PC2—metabolic syndrome X	2.69e-05	0.000489	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	2.68e-05	0.000488	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CD36—metabolic syndrome X	2.68e-05	0.000487	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—MLXIPL—metabolic syndrome X	2.67e-05	0.000486	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—EPHX2—metabolic syndrome X	2.67e-05	0.000486	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOB—metabolic syndrome X	2.66e-05	0.000485	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—FABP4—metabolic syndrome X	2.62e-05	0.000478	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NAMPT—metabolic syndrome X	2.62e-05	0.000476	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL5—metabolic syndrome X	2.6e-05	0.000474	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.6e-05	0.000474	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LIPC—metabolic syndrome X	2.6e-05	0.000473	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GCK—metabolic syndrome X	2.6e-05	0.000473	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PLA2G4A—metabolic syndrome X	2.59e-05	0.000472	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOC3—metabolic syndrome X	2.58e-05	0.000471	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LPL—metabolic syndrome X	2.54e-05	0.000463	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—G6PC2—metabolic syndrome X	2.51e-05	0.000457	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CETP—metabolic syndrome X	2.51e-05	0.000457	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARA—metabolic syndrome X	2.49e-05	0.000453	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HSD11B1—metabolic syndrome X	2.49e-05	0.000453	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	2.43e-05	0.000442	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	2.41e-05	0.000439	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AGT—metabolic syndrome X	2.41e-05	0.000439	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SCARB1—metabolic syndrome X	2.4e-05	0.000437	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	2.39e-05	0.000435	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOE—metabolic syndrome X	2.36e-05	0.00043	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	2.34e-05	0.000427	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.34e-05	0.000426	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APOA1—metabolic syndrome X	2.33e-05	0.000425	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SREBF1—metabolic syndrome X	2.33e-05	0.000425	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	2.31e-05	0.000421	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	2.3e-05	0.000419	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—FABP4—metabolic syndrome X	2.29e-05	0.000416	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMGCR—metabolic syndrome X	2.27e-05	0.000413	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GOT2—metabolic syndrome X	2.27e-05	0.000413	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—G6PD—metabolic syndrome X	2.22e-05	0.000404	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	2.19e-05	0.000398	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AGT—metabolic syndrome X	2.18e-05	0.000396	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	2.17e-05	0.000394	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HDAC3—metabolic syndrome X	2.16e-05	0.000394	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—FABP4—metabolic syndrome X	2.13e-05	0.000389	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—metabolic syndrome X	2.13e-05	0.000388	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOE—metabolic syndrome X	2.13e-05	0.000388	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCKR—metabolic syndrome X	2.11e-05	0.000385	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPA—metabolic syndrome X	2.11e-05	0.000385	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—APOA1—metabolic syndrome X	2.11e-05	0.000384	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PPARG—metabolic syndrome X	2.06e-05	0.000375	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G6—metabolic syndrome X	2.05e-05	0.000373	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	2.05e-05	0.000373	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.03e-05	0.00037	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA5—metabolic syndrome X	2.03e-05	0.000369	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HSD11B1—metabolic syndrome X	2.02e-05	0.000368	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ABCA1—metabolic syndrome X	2.02e-05	0.000368	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—SLC2A4—metabolic syndrome X	2.02e-05	0.000368	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—INS—metabolic syndrome X	2.02e-05	0.000367	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	2e-05	0.000364	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	1.99e-05	0.000363	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.97e-05	0.000358	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	1.96e-05	0.000357	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GGT1—metabolic syndrome X	1.96e-05	0.000357	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GOT1—metabolic syndrome X	1.96e-05	0.000357	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—G6PD—metabolic syndrome X	1.93e-05	0.000352	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.93e-05	0.000351	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	1.91e-05	0.000347	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.91e-05	0.000347	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IRS1—metabolic syndrome X	1.9e-05	0.000346	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HDAC3—metabolic syndrome X	1.88e-05	0.000343	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—TRIB3—metabolic syndrome X	1.88e-05	0.000343	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	1.87e-05	0.000341	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	1.86e-05	0.000339	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—metabolic syndrome X	1.85e-05	0.000337	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCKR—metabolic syndrome X	1.84e-05	0.000335	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPA—metabolic syndrome X	1.84e-05	0.000335	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—INS—metabolic syndrome X	1.82e-05	0.000332	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—G6PD—metabolic syndrome X	1.8e-05	0.000328	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CCL2—metabolic syndrome X	1.79e-05	0.000326	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	1.78e-05	0.000325	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	1.78e-05	0.000324	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—metabolic syndrome X	1.77e-05	0.000322	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA5—metabolic syndrome X	1.77e-05	0.000322	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IGF1—metabolic syndrome X	1.76e-05	0.000321	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HDAC3—metabolic syndrome X	1.76e-05	0.000321	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPA—metabolic syndrome X	1.72e-05	0.000313	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCKR—metabolic syndrome X	1.72e-05	0.000313	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NAMPT—metabolic syndrome X	1.69e-05	0.000308	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	1.68e-05	0.000307	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.68e-05	0.000306	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LIPC—metabolic syndrome X	1.68e-05	0.000306	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCK—metabolic syndrome X	1.68e-05	0.000306	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.67e-05	0.000305	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOC3—metabolic syndrome X	1.67e-05	0.000304	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G6—metabolic syndrome X	1.67e-05	0.000303	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOB—metabolic syndrome X	1.66e-05	0.000303	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	1.65e-05	0.000301	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA5—metabolic syndrome X	1.65e-05	0.0003	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—TRIB3—metabolic syndrome X	1.64e-05	0.000299	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CETP—metabolic syndrome X	1.62e-05	0.000295	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—PTGS2—metabolic syndrome X	1.62e-05	0.000295	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PLA2G4A—metabolic syndrome X	1.62e-05	0.000294	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	1.6e-05	0.000292	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—metabolic syndrome X	1.6e-05	0.000291	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—LPL—metabolic syndrome X	1.59e-05	0.000289	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	1.58e-05	0.000288	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	1.57e-05	0.000286	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	1.55e-05	0.000283	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SCARB1—metabolic syndrome X	1.55e-05	0.000283	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—TRIB3—metabolic syndrome X	1.53e-05	0.000279	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.51e-05	0.000275	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CD36—metabolic syndrome X	1.51e-05	0.000275	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SREBF1—metabolic syndrome X	1.51e-05	0.000274	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NAMPT—metabolic syndrome X	1.47e-05	0.000268	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMGCR—metabolic syndrome X	1.47e-05	0.000267	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT2—metabolic syndrome X	1.47e-05	0.000267	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LIPC—metabolic syndrome X	1.46e-05	0.000266	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCK—metabolic syndrome X	1.46e-05	0.000266	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOC3—metabolic syndrome X	1.45e-05	0.000265	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CETP—metabolic syndrome X	1.41e-05	0.000257	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARA—metabolic syndrome X	1.4e-05	0.000255	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	1.39e-05	0.000252	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NAMPT—metabolic syndrome X	1.38e-05	0.00025	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.37e-05	0.000249	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	1.37e-05	0.000249	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LIPC—metabolic syndrome X	1.37e-05	0.000249	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCK—metabolic syndrome X	1.37e-05	0.000249	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOC3—metabolic syndrome X	1.36e-05	0.000247	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AGT—metabolic syndrome X	1.36e-05	0.000247	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SCARB1—metabolic syndrome X	1.35e-05	0.000246	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—metabolic syndrome X	1.35e-05	0.000245	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOE—metabolic syndrome X	1.33e-05	0.000242	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.32e-05	0.000241	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CETP—metabolic syndrome X	1.32e-05	0.00024	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APOA1—metabolic syndrome X	1.31e-05	0.000239	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SREBF1—metabolic syndrome X	1.31e-05	0.000239	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ABCA1—metabolic syndrome X	1.31e-05	0.000238	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—SLC2A4—metabolic syndrome X	1.31e-05	0.000238	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMGCR—metabolic syndrome X	1.28e-05	0.000232	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT2—metabolic syndrome X	1.28e-05	0.000232	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GGT1—metabolic syndrome X	1.26e-05	0.00023	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GOT1—metabolic syndrome X	1.26e-05	0.00023	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SCARB1—metabolic syndrome X	1.26e-05	0.00023	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	1.25e-05	0.000228	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—AKT1—metabolic syndrome X	1.24e-05	0.000226	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	1.23e-05	0.000224	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SREBF1—metabolic syndrome X	1.23e-05	0.000223	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMGCR—metabolic syndrome X	1.19e-05	0.000217	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT2—metabolic syndrome X	1.19e-05	0.000217	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PPARG—metabolic syndrome X	1.16e-05	0.000211	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ABCA1—metabolic syndrome X	1.14e-05	0.000207	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	1.14e-05	0.000207	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—INS—metabolic syndrome X	1.14e-05	0.000207	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GOT1—metabolic syndrome X	1.1e-05	0.000201	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GGT1—metabolic syndrome X	1.1e-05	0.000201	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.08e-05	0.000196	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOB—metabolic syndrome X	1.07e-05	0.000195	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ABCA1—metabolic syndrome X	1.06e-05	0.000194	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—SLC2A4—metabolic syndrome X	1.06e-05	0.000194	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—metabolic syndrome X	1.06e-05	0.000192	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PLA2G4A—metabolic syndrome X	1.04e-05	0.00019	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—metabolic syndrome X	1.04e-05	0.00019	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GGT1—metabolic syndrome X	1.03e-05	0.000187	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GOT1—metabolic syndrome X	1.03e-05	0.000187	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—LPL—metabolic syndrome X	1.02e-05	0.000187	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—metabolic syndrome X	9.96e-06	0.000181	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CD36—metabolic syndrome X	9.74e-06	0.000177	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOB—metabolic syndrome X	9.35e-06	0.00017	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—PTGS2—metabolic syndrome X	9.11e-06	0.000166	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	9.1e-06	0.000166	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARA—metabolic syndrome X	9.05e-06	0.000165	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—LPL—metabolic syndrome X	8.93e-06	0.000163	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AGT—metabolic syndrome X	8.77e-06	0.00016	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOB—metabolic syndrome X	8.74e-06	0.000159	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOE—metabolic syndrome X	8.59e-06	0.000156	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	8.5e-06	0.000155	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APOA1—metabolic syndrome X	8.49e-06	0.000155	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CD36—metabolic syndrome X	8.48e-06	0.000154	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—LPL—metabolic syndrome X	8.34e-06	0.000152	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—AKT1—metabolic syndrome X	8.13e-06	0.000148	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—metabolic syndrome X	7.96e-06	0.000145	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CD36—metabolic syndrome X	7.93e-06	0.000144	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARA—metabolic syndrome X	7.89e-06	0.000144	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AGT—metabolic syndrome X	7.64e-06	0.000139	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOE—metabolic syndrome X	7.48e-06	0.000136	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PPARG—metabolic syndrome X	7.48e-06	0.000136	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APOA1—metabolic syndrome X	7.4e-06	0.000135	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARA—metabolic syndrome X	7.37e-06	0.000134	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—AKT1—metabolic syndrome X	7.34e-06	0.000134	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—INS—metabolic syndrome X	7.34e-06	0.000134	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AGT—metabolic syndrome X	7.14e-06	0.00013	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOE—metabolic syndrome X	6.99e-06	0.000127	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APOA1—metabolic syndrome X	6.91e-06	0.000126	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—metabolic syndrome X	6.73e-06	0.000123	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PPARG—metabolic syndrome X	6.52e-06	0.000119	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—metabolic syndrome X	6.44e-06	0.000117	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—INS—metabolic syndrome X	6.39e-06	0.000116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PPARG—metabolic syndrome X	6.09e-06	0.000111	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—INS—metabolic syndrome X	5.97e-06	0.000109	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	5.89e-06	0.000107	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—metabolic syndrome X	5.86e-06	0.000107	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—metabolic syndrome X	5.61e-06	0.000102	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—metabolic syndrome X	5.48e-06	9.97e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5.24e-06	9.54e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—PTGS2—metabolic syndrome X	5.13e-06	9.34e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	4.79e-06	8.72e-05	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—AKT1—metabolic syndrome X	4.58e-06	8.34e-05	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—AKT1—metabolic syndrome X	2.96e-06	5.39e-05	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—AKT1—metabolic syndrome X	2.58e-06	4.69e-05	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.41e-06	4.38e-05	CbGpPWpGaD
